The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma

Neuro-Oncology

Volumn 15, Issue 5, 2013, Pages 635-643

  Rooney, Alasdair Grant ^a   McNamara, Shanne ^a   MacKinnon, Mairi ^b   Fraser, Mary ^b   Rampling, Roy ^b   Carson, Alan ^a   Grant, Robin ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

distress; distress thermometer; glioma

Indexed keywords

ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; TEMOZOLOMIDE;

ARTICLE; CANCER RADIOTHERAPY; COGNITIVE DEFECT; DISEASE ASSOCIATION; DYSPHASIA; EMOTIONAL STRESS; FEMALE; FOLLOW UP; GLIOMA; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; VISUAL IMPAIRMENT;

ADULT; BRAIN NEOPLASMS; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSPECTIVE STUDIES; STRESS, PSYCHOLOGICAL; TERTIARY CARE CENTERS;

EID: 84877133862     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not009     Document Type: Article

References (16)

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008 (March 23, 2012 revision). Hinsdale, IL: Central Brain Tumor Registry of the United States; 2010.
2. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008; 359: 492-507.
3. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10: 459-466.
4. NCCN.NCCNclinical practice guidelines in oncology: distressmanagement. 2012. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed September 18, 2012.
5. Goebel S, Mehdorn M. Measurement of psychological distress in patients with intracranial tumours: the NCCN Distress Thermometer. J Neurooncol. 2011; 104: 357-364.
6. Goebel S, Stark AM, von Harscher M, Mehdorn HM. Distress in patients with newly diagnosed brain tumours. Psychooncology. 2011; 20: 623-630.
7. Keir ST, Calhoun-Eagan RD, Swartz JJ, Saleh OA, Friedman HS. Screening for distress in patients with brain cancer using the NCCN's rapid screening measure. Psychooncology. 2008; 17: 621-625.
8. Keir ST, Farland MM, Lipp ES, Friedman HS. Distress persists in longterm brain tumor survivors with glioblastoma multiforme. J Cancer Surviv. 2008; 2: 269-274.
9. Kvale EAM. Distress and quality of life in primary high-grade brain tumor patients. Supp Care Cancer. 2009; 17: 793-799.
10. Rooney AG, McNamara S, MacKinnon M, et al. Frequency, clinical associations and longitudinal course of major depressive disorder in adults with cerebral glioma. J Clin Oncol. 2011; 29: 4307-4312.
11. Peduzzi P, Concato J, Kemper T, Holford R, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996; 49: 1373-1379.
12. Sprangers MA, Schwartz CE. Integrating response shift into healthrelated quality of life research: a theoretical model. Soc Sci Med. 1999; 48: 1507-1515.
13. Graves KD, Arnold SM, Love CL, et al. Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer. 2007; 55: 215-224.
14. Akizuki N, Akechi T, Nakanishi T, et al. Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer. 2003; 97: 2605-2613.
15. Hurria A, Li D, Hansen K, et al. Distress in older patients with cancer. J Clin Oncol. 2009; 27: 4346-4351.
16. Rooney AG, van Nieuwenhuizen D, Reijneveld JC, Grant R. Female gender is not a proven risk factor for depression in glioma. J Neurooncol. 2009; 95: 449.